178 results
DEFA14A
PBLA
Panbela Therapeutics, Inc.
25 Apr 24
Additional proxy soliciting materials
4:36pm
contains “forward-looking statements,” including within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements
8-K
PBLA
Panbela Therapeutics, Inc.
25 Apr 24
Entry into a Material Definitive Agreement
4:35pm
This report contains “forward-looking statements,” including within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking
8-K
EX-99.1
PBLA
Panbela Therapeutics, Inc.
22 Apr 24
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
8:02am
contains “forward-looking statements,” including within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements
POS AM
vhqtk xat2n5o5
29 Mar 24
Prospectus update (post-effective amendment)
5:08pm
8-K
EX-99.1
7r6vtozbj17evcmbjwd4
26 Mar 24
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
4:12pm
8-K
bm5skpkm
7 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:01am
8-K
EX-99.1
d7d4 57jg1vps2
15 Feb 24
Regulation FD Disclosure
8:05am
8-K
EX-99.1
6xymbqprzg7p67jsy1z
1 Feb 24
Panbela Announces Closing of Approximately $9.0 Million Public Offering
7:15am
8-K
u150m9jys dx
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am
8-K
EX-99.1
1kxxovlb
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am
8-K
EX-10.2
v74x4sf6c ru
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am